Skip to main content
. 2008 May;4(5):337–347.

Table 1.

Glucocorticosteroid (GCS) Drug Interactions

Drug Drug-Drug Interaction Cytochrome Association Renal Impairment Hepatic Impairment
Prednisone
Budesonide
M-prednisolone
Prednisolone
Dexamethasone
Aminoglutethimide: decreases levels/therapeutic effects of GCS
Amphotericin: increases hypokalemic effects of amphotericin B
Antacid: may decrease the absorption of GCS
Anticholinesterase: concurrent use can lead to profound weakness in myasthenia gravis patients
Antidiabetic agents: may decrease hypoglycemic effects of diabetic medications
Aprepitant: may increase serum levels/therapeutic effects of GCS
Antifungal agents: may increase serum levels/therapeutic effects of GCS
Barbiturates: may decrease levels/therapeutic effects of GCS
Bile acid sequestrants: may reduce absorption of GCS
Calcium channel blockers: may increase serum levels/therapeutic effects of GCS
Cyclosporine: concurrent use may increase levels of cyclosporine
Diuretics: hypokalemic effects may be increased
Estrogens: may increase serum levels/therapeutic effects of GCS
Fluoroquinolones: concurrent use can increase risk of tendinopathies (tendonitis, rupture), particularly in the elderly
Isoniazid: decreased serum levels/therapeutic effects of GCS
Macrolides: may increase serum levels/therapeutic effects of GCS
Neuromuscular-blocking agents: concurrent use increases the risk of myopathy
NSAIDs: concurrent use may lead to increased incidence of GI adverse effects
Rifamycin derivatives: may decrease the levels/therapeutic effects of GCS
Salicylates: concurrent use may increase GI adverse effects
Thalidomide: concurrent use may increase the risk of toxic epidermal necrolysis and DVT
Vaccine (dead organism): may decrease the effect of vaccines
Vaccine (live organism): may increase the risk of infection. Usage of live vaccines is contraindicated in immunosuppressed patients
Warfarin: concurrent use may increase anticoagulant effects
Note: Corticosteroids interfere with calcium absorption. St. John's Wort may decrease corticosteroid levels.
Substrate of CYP3A4
Induces CYP2C19, 3A4
Use with caution— fluid retention may occur Use with caution— fluid retention may occur
DVT

deep vein thrombosis

GI

gastrointestinal

NSAIDS

nonsteroidal anti-inflammatory drugs.